<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04585854</url>
  </required_header>
  <id_info>
    <org_study_id>2020-01876</org_study_id>
    <nct_id>NCT04585854</nct_id>
  </id_info>
  <brief_title>Effect of Caffeine on Myocardial Oxygenation</brief_title>
  <acronym>Coffee-O2</acronym>
  <official_title>Effect of Caffeine on Myocardial Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the impact of caffeine on myocardial oxygenation&#xD;
      and other cardiovascular magnetic resonance parameters in healthy controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Caffeine is presumed to create a confounder with diagnostic imaging. The vasodilatory&#xD;
      capacity is considered a key measure for the detection of significant coronary disease with&#xD;
      stenosed epicardial arterial conduit vessels and overall microvascular function, including&#xD;
      endothelial dysfunction. Twenty nine healthy controls will undergo a baseline cardiovascular&#xD;
      magnetic resonance (CMR) exam. Afterwards, participants will consume coffee in the presence&#xD;
      of study personnel. This will consist of 3 espresso shots, which will be consumed within 15&#xD;
      minutes. Approximately 2h after coffee consumption the CMR exam will be repeated. The goal&#xD;
      will be to investigate the impact of caffeine on myocardial features. In particular the&#xD;
      effect on the myocardial oxygenation response to vasodilating and vasoconstricting stimuli.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 13, 2020</start_date>
  <completion_date type="Actual">October 23, 2021</completion_date>
  <primary_completion_date type="Actual">October 23, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Controlled before-after comparison</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Blinded image analysis</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in myocardial oxygenation responses</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Percent (%) Measure of oxygenation-sensitive signal change measured by CMR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in ejection fraction</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Percent (%), measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in cardiac index</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>L/min/m2, measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in myocardial peak strain</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Percent (%), a measure of systolic function (shortening and thickening) of the myocardium measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in myocardial time to peak strain</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Milliseconds (ms), measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in myocardial strain rate</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Change in strain over time (/second), measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in myocardial parametric mapping</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Milliseconds (ms), measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in 4D blood flow</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Percent, measured by CMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in rate pressure product</measure>
    <time_frame>Through study completion up to 5 hours, before and after caffeine</time_frame>
    <description>Blood pressure * heart rate</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Caffeine</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control population who will undergo two cardiovascular magnetic resonance exams: one at rest and one after drinking caffeine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>Consumption of 3 shots of espresso</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Coffee</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to give informed consent, documented by signature&#xD;
&#xD;
          -  Aged 18 to 45&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MRI Contraindications following current institutional guidelines at the time of the&#xD;
             CMR exam&#xD;
&#xD;
          -  Knowledge or suspicion of pregnancy (verified with a pregnancy test).&#xD;
&#xD;
          -  Consumption of caffeine 12h prior to the baseline CMR exam (outside of the study&#xD;
             protocol).&#xD;
&#xD;
          -  Known cardiovascular disease, diabetes, severe respiratory disease, obstructive sleep&#xD;
             apnea syndrome, chemotherapy and radiation treatment, cerebrovascular and occlusive&#xD;
             peripheral vascular disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominik P Guensch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bern University Hospital, Inselspital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bern University Hospital, Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Fischer K, Yamaji K, Luescher S, Ueki Y, Jung B, von Tengg-Kobligk H, Windecker S, Friedrich MG, Eberle B, Guensch DP. Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers. J Cardiovasc Magn Reson. 2018 May 7;20(1):31. doi: 10.1186/s12968-018-0446-y.</citation>
    <PMID>29730991</PMID>
  </reference>
  <reference>
    <citation>van Dijk R, Ties D, Kuijpers D, van der Harst P, Oudkerk M. Effects of Caffeine on Myocardial Blood Flow: A Systematic Review. Nutrients. 2018 Aug 13;10(8). pii: E1083. doi: 10.3390/nu10081083. Review.</citation>
    <PMID>30104545</PMID>
  </reference>
  <reference>
    <citation>Kuijpers D, Prakken NH, Vliegenthart R, van Dijkman PR, van der Harst P, Oudkerk M. Caffeine intake inverts the effect of adenosine on myocardial perfusion during stress as measured by T1 mapping. Int J Cardiovasc Imaging. 2016 Oct;32(10):1545-53. doi: 10.1007/s10554-016-0949-2. Epub 2016 Jul 29.</citation>
    <PMID>27473274</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CMR</keyword>
  <keyword>Myocardial oxygenation</keyword>
  <keyword>Myocardial Function</keyword>
  <keyword>Coffee</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

